
|Videos|December 13, 2022
Importance of Clinical Trial Data, Disease Control, and QoL in Atopic Dermatitis Management
Author(s)Raj Chovatiya, MD, PhD, MSCI, Neal Bhatia, MD
Raj Chovatiya, M.D., Ph.D. and Neal Bhatia, MD comment on the importance of assessing a treatment’s available clinical trial data, ability to control disease severity, and QoL impacts when assessing atopic dermatitis treatment options.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Social Media Mythbusters: The Summer Skin Care "Shutdown"
2
Zasocitinib Shows High Skin Clearance at Hard-to-Treat Psoriasis Sites
3
ED Treatment Gaps Persist for Pediatric Atopic Dermatitis
4
Breakout Bulletin: July 13-July 17
5















